⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Colorectal Cancer Screening in Cystic Fibrosis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Colorectal Cancer Screening in Cystic Fibrosis

Official Title: A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)

Study ID: NCT05362344

Interventions

Stool tests

Study Description

Brief Summary: This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).

Detailed Description: NICE-CF is a cross-sectional, multi-center study comparing stool-based testing (multi-target DNA test and quantitative FIT test) to standard of care colonoscopy for colorectal cancer (CRC) screening in people with CF. The study includes an enrollment visit, two stool samples completed at home, a clinical screening colonoscopy, and three participant surveys which will be completed at enrollment or remotely. The total duration of participant participation will be 3-12 months, depending on the timing of the completion of the stool samples and the participant's colonoscopy. The targeted participant timeline is 3 months from enrollment to the completion of a clinical screening colonoscopy. To allow for varying site-specific clinical colonoscopy scheduling delays and COVID delays in scheduling, the duration of time between submitting stool samples and screening colonoscopy may extend up to 12 months for inclusion of data in the study. However, participating sites must notify the DCC to obtain preapproval for greater than 3 months duration between stool-based testing and colonoscopy. CF patients who are eligible for CRC screening will either be enrolled during an in-person CF clinic visit or via phone/video if clinic visits are taking place remotely. Participants will be asked to perform stool sample collection at home, and then complete their colonoscopy within three to twelve months of submission of the stool sample.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California, Los Angeles, Los Angeles, California, United States

Stanford University Medical Center, Palo Alto, California, United States

National Jewish Health, University of Colorado, Denver, Colorado, United States

University of Miami Hospital, Miami, Florida, United States

University of Kansas Medical Center, Kansas City, Kansas, United States

Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Boston Children's Hospital, Boston, Massachusetts, United States

Michigan Medicine - University of Michigan, Ann Arbor, Michigan, United States

University of Minnesota, Minneapolis, Minnesota, United States

Saint Louis University, Saint Louis, Missouri, United States

Washington University, Saint Louis, Missouri, United States

Columbia University Medical Center, New York, New York, United States

North Carolina Children's Hospital / UNC, Chapel Hill, North Carolina, United States

Atrium Health Pulmonary Care, Charlotte, North Carolina, United States

University Hospitals Rainbow Babies & Children's, Cleveland, Ohio, United States

Nationwide Children's Hospital, Columbus, Ohio, United States

Oregon Health & Science University, Portland, Oregon, United States

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Medical University of South Carolina, Charleston, South Carolina, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

University of Texas Southwestern, Dallas, Texas, United States

University of Utah, Salt Lake City, Utah, United States

University of Washington, Seattle, Washington, United States

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Contact Details

Name: Christine Hachem, MD

Affiliation: St. Louis University

Role: PRINCIPAL_INVESTIGATOR

Name: Sarah Jane Schwarzenberg, MD

Affiliation: University of Minnesota

Role: PRINCIPAL_INVESTIGATOR

Name: Steven D. Freedman, MD, PhD

Affiliation: Beth Israel Deaconess Medical Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: